Literature DB >> 15635026

Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity.

Elisabeth Puchhammer-Stöckl1, Brigitte Schmied, Armin Rieger, Mario Sarcletti, Maria Geit, Robert Zangerle, Hanns Hofmann.   

Abstract

The time between human immunodeficiency virus (HIV) infection and diagnosis is mostly unknown. Two hundred five newly diagnosed patients were investigated for the duration of their HIV infection by avidity testing. Recent HIV infection was identified in 27.3% of the cases. Early diagnosis was achieved significantly less frequently in heterosexually infected persons than in other patients.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15635026      PMCID： PMC540163          DOI： 10.1128/JCM.43.1.497-498.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance.

Authors: 
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

2.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

3.  Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy.

Authors:  M Eggers; U Bäder; G Enders
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

4.  Antibody avidity following varicella-zoster virus infections.

Authors:  H O Kangro; S Manzoor; D R Harper
Journal:  J Med Virol       Date:  1991-02       Impact factor: 2.327

5.  Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method.

Authors:  Barbara Suligoi; Claudio Galli; Mario Massi; Fiorella Di Sora; Mauro Sciandra; Patrizio Pezzotti; Olga Recchia; Francesco Montella; Alessandro Sinicco; Giovanni Rezza
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Clinical and epidemiologic features of primary HIV infection.

Authors:  T Schacker; A C Collier; J Hughes; T Shea; L Corey
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

7.  Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations.

Authors:  L Matter; K Kogelschatz; D Germann
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

8.  Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.

Authors:  Andrew J Leigh Brown; Simon D W Frost; W Christopher Mathews; Keith Dawson; Nicholas S Hellmann; Eric S Daar; Douglas D Richman; Susan J Little
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

9.  Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings.

Authors:  Amy C Weintrob; Julieta Giner; Prema Menezes; Ericka Patrick; Daniel Kelly Benjamin; Jeffrey Lennox; Christopher D Pilcher; Joseph J Eron; Charles B Hicks
Journal:  Arch Intern Med       Date:  2003-09-22

10.  Time trends in primary HIV-1 drug resistance among recently infected persons.

Authors:  Robert M Grant; Frederick M Hecht; Maria Warmerdam; Lea Liu; Teri Liegler; Christos J Petropoulos; Nicholas S Hellmann; Margaret Chesney; Michael P Busch; James O Kahn
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272
View more
  5 in total

1.  Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Authors:  Harry E Prince; Mary Lapé-Nixon; Michael P Busch; Leslie H Tobler; Gregory A Foster; Susan L Stramer
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections.

Authors:  Stephan Loschen; Jörg Bätzing-Feigenbaum; Gabriele Poggensee; Christiane Cordes; Bettina Hintsche; Michael Rausch; Stephan Dupke; Silvia Gohlke-Micknis; Jana Rödig; Osamah Hamouda; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

3.  HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy.

Authors:  Alessia Mammone; Patrizio Pezzotti; Claudio Angeletti; Nicoletta Orchi; Angela Carboni; Assunta Navarra; Maria R Sciarrone; Catia Sias; Vincenzo Puro; Gabriella Guasticchi; Giuseppe Ippolito; Piero Borgia; Enrico Girardi
Journal:  BMC Infect Dis       Date:  2012-03-20       Impact factor: 3.090

4.  Epidemiological factors associated with recent HIV infection among newly-diagnosed cases in Singapore, 2013-2017.

Authors:  Li Wei Ang; Carmen Low; Chen Seong Wong; Irving Charles Boudville; Matthias Paul Han Sim Toh; Sophia Archuleta; Vernon Jian Ming Lee; Yee Sin Leo; Angela Chow; Raymond Tzer-Pin Lin
Journal:  BMC Public Health       Date:  2021-03-02       Impact factor: 3.295

5.  Elevated risk for HIV-1 infection in adolescents and young adults in São Paulo, Brazil.

Authors:  Katia Cristina Bassichetto; Denise Pimentel Bergamaschi; Solange Maria Oliveira; Marylei Casteldelli Verri Deienno; Reginaldo Bortolato; Heloíza Vilma de Rezende; Thaís Arthur; Helena Tomiyama; Colyn Watkins; Fabio Mesquita; Maria Cristina Abbate; Esper Georges Kallas
Journal:  PLoS One       Date:  2008-01-09       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.